Snyder Mark Howard sold HALO
February 23, 2026 · Form 4 insider transaction
Snyder Mark Howard sold 3,782 shares of Halozyme Therapeutics, Inc. at $70.64 per share, a transaction worth $267.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,782
Price
$70.64
Total value
$267.2K
InsiderSnyder Mark Howard
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 23, 2026
Filing dateFebruary 24, 2026
Shares owned after47,610
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported disposition of 3,782 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.